The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model

Arthritis and Rheumatism

Volumn 54, Issue 2, 2006, Pages 482-491

  Von Delwig, Alexei ^a   Altmann, Daniel M ^b   Isaacs, John D ^a   Harding, Clifford V ^c   Holmdahl, Rikard ^d   McKie, Norman ^a   Robinson, John H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; COLLAGEN TYPE 2; CYSTEINE PROTEINASE INHIBITOR; EPITOPE; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELLULAR IMMUNITY; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; HYBRIDOMA; LYSOSOME; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLLAGEN TYPE II; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; GLYCOSYLATION; HLA-DR1 ANTIGEN; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL;

EID: 31144457855     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21565     Document Type: Article

References (50)

1. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998;76:275-88.
2. Holmdahl R, Andersson EC, Andersen CB, Svejgaard A, Fugger L. Transgenic mouse models of rheumatoid arthritis. Immunol Rev 1999;169:161-73.
3. Van den Berg WB. Animal models of arthritis: what have we learned? J Rheumatol 2005;72:7-9.
4. Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994;24:1698-702.
5. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997;61:1861-78.
6. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997;185:1113-22.
7. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998;160:2573-8.
8. Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A 1998;95:7574-9.
9. Harney SM, Newton JL, Wordsworth BP. Molecular genetics of rheumatoid arthritis [review]. Curr Opin Pharmacol 2003;3:280-5.
10. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end [review]. Arthritis Rheum 2002;46:298-308.
11. Kim WU, Kim KJ. T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis. J Rheumatol 2005;32:225-30.
12. Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A 2002;99:9960-5.
13. Ohnishi Y, Tsutsumi A, Sakamaki T, Sumida T. T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis. Int J Mol Med 2003;11:331-5.
14. Kim HY, Kim WU, Cho ML, Lee SK, Youn J, Kim SI, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.
15. Anderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 2004;16:753-8.
16. Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994;180:745-9.
17. Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002;32:3776-84.
18. Holmdahl R, Bockermann R, Backlund J, Yamada H. The molecular pathogenesis of collagen-induced arthritis in mice: a model for rheumatoid arthritis. Ageing Res Rev 2002;1:135-47.
19. Doncarli A, Chiocchia G, Stasiuk LM, Herbage D, Boutillon MM, Fournier C, et al. A recurrent vα17/Vβ10 TCR-expressing T cell clone is involved in the pathogenicity of collagen-induced arthritis in DBA/1 mice. Eur J Immunol 1999;29:3636-42.
20. q antigen-presenting cells. Eur J Immunol 1995;25:3235-42.
21. Michaelsson E, Holmdahl M, Engstrom A, Burkhardt H, Scheynius A, Holmdahl R. Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol 1995;25:2234-41.
22. Manoury-Schwartz B, Chiocchia G, Lotteau V, Fournier C. Selective increased presentation of type II collagen by leupeptin. Int Immunol 1997;9:581-9.
23. Dzhambazov B, Holmdahl M, Yamada H, Lu S, Vestberg M, Holm B, et al. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol 2005;35:357-66.
24. Holmdahl M, Grubb A, Holmdahl R. Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int Immunol 2004;16:717-26.
25. Holm B, Baquer SM, Holm L, Holmdahl R, Kihlberg J. Role of the galactosyl moiety of collagen glycopeptides for T-cell stimulation in a model for rheumatoid arthritis. Bioorg Med Chem 2003;11:3981-7.
26. Altmann DM, Douek DC, Frater AJ, Hetherington CM, Inoko H, Elliott JI. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med 1995;181:867-75.
27. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C. et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-66.
28. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo) 1970;23:259-62.
29. Takahashi H, Cease KB, Berzofsky JA. Identification of proteases that process distinct epitopes on the same protein. J Immunol 1989;142:2221-9.
30. Delvig AA, Robinson JH. Different endosomal proteolysis requirements for antigen processing of two T-cell epitopes of the M5 protein from viable Streptococcus pyogenes. J Biol Chem 1998;273:3291-5.
31. Tamai M, Matsumoto K, Omura S, Koyama I, Ozawa Y, Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analogue of E-64. J Pharmacobiodyn 1986;9:672-7.
32. Etherington DJ, Pugh D, Silver IA. Collagen degradation in an experimental inflammatory lesion: studies on the role of the macrophage. Acta Biol Med Ger 1981;40:1625-36.
33. Delvig AA, Robinson JH. Two T-cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages. J Immunol 1998;160:5267-72.
34. Ramachandra L, Harding CV. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. J Immunol 2000;164:5103-12.
35. Von Delwig A, Musson JA, McKie N, Gray J, Robinson JH. Regulation of peptide presentation by major histocompatibility complex class II molecules at the surface of macrophages. Eur J Immunol 2003;33:3359-66.
36. Graham JM. Subcellular fractionation and isolation of organelles: isolation of lysosomes from tissues and cells by differential and density gradient centrifugation. In: Bonifacino JS, Dasso M, Hartford JB, Lippincott-Schwartz J, Yamada KM, editors. Current protocols in cell biology. New York: John Wiley & Sons; 2000. p. 1-21.
37. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669-76.
38. Kubo K, Takagi T. The α1(I) and α2(I) chains of collagen separate in sodium dodecyl sulfate-polyacrylamide gel electrophoresis due to differences in sodium dodecyl sulfate binding capacities. Coll Relat Res 1984;4:201-8.
39. Watts C. Antigen processing in the endocytic compartment. Curr Opin Immunol 2001;13:26-31.
40. p molecules. Eur J Immunol 1998;28:755-67.
41. Creemers LB, Hoeben KA, Jansen DC, Buttle DJ, Beersten W, Everts V. Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. Matrix Biol 1998;16:575-84.
42. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998;273:32347-52.
43. Maciewicz RA, Etherington DJ. A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem J 1988;256:433-40.
44. Everts V, Korper W, Niehof A, Jansen I, Beersten W. Type VI collagen is phagocytosed by fibroblasts and digested in the lysosomal apparatus; involvement of collagenase, serine proteinases and lysosomal enzymes. Matrix Biol 1994;14:665-76.
45. Ludewig B, Junt T, Hengartner H, Zinkernagel RM. Dendritic cells in autoimmune diseases. Curr Opin Immunol 2001;13:657-62.
46. Chan VS, Cohen ES, Weissensteiner T, Cheah KS, Bodmer HC. Chondrocyte antigen expression, immune response and susceptibility to arthritis. Int Immunol 2001;13:421-9.
47. Saudek DM, Kay J. Advanced glycation endproducts and osteoarthritis. Curr Rheumatol Rep 2003;5:33-40.
48. DeGroot J. The AGE of the matrix; chemistry, consequence and cure. Curr Opin Pharmacol 2004;4:301-5.
49. Leikina E, Merits MV, Kuznetsova N, Leikin S. Type I collagen is thermally unstable at body temperature. Proc Natl Acad Sci U S A 2002;99:1314-8.
50. Lundberg K, Ottosson L, Westman E, Sunnerhagen M, Hultenby K, Harris HE. A pH-induced modification of CII increases its arthritogenic properties. Autoimmunity 2004;23:95-102.